Trial Profile
A Phase 2 Study of WEE1 Inhibition With AZD1775 Alone or Combined With Cytarabine in Patients With Advanced Acute Myeloid Leukemia and Myelodysplastic Syndrome
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Adavosertib (Primary) ; Cytarabine
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes
- Focus Biomarker; Therapeutic Use
- 05 Nov 2018 Status changed from suspended to completed.
- 02 Aug 2018 Status changed from recruiting to suspended as the closure is in preparation for possible IND transfer to external PI and institution
- 27 Jun 2017 Status changed from not yet recruiting to recruiting.